Chrysovalantis Voutouri

11PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersBiomaterialsCancer therapy (excl. chemotherapy and radiation therapy)NanomedicineMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 27, 2026
Computational Pathology Reveals Extracellular-Matrix Imaging Biomarkers of Therapy Response in Preclinical Breast Cancer.

|May 18, 2026
Synthetic Inducible Bacteria Normalize the Microenvironment of Refractory Tumors, Potentiating Checkpoint Inhibitor Responses.

|May 02, 2026
Synthetic inducible bacteria normalize the microenvironment of refractory tumors, potentiating checkpoint inhibitor responses.

|Jan 30, 2026
Ensemble Machine Learning on Bulk RNA-Seq Identifies 17-Gene Signature Predicting Neoadjuvant Chemotherapy Response in Breast Cancer.

Stelios Lamprou, Styliana Georgiou, Triantafyllos Stylianopoulos

|Nov 28, 2025
Antiemesis Corticosteroids Potentiate Checkpoint Blockade Efficacy by Normalizing the Immune Microenvironment in Metastatic Murine Breast Cancer.

John D Martin, Koji Nagaoka, Myrofora Panagi

|Jun 12, 2025
Biomarkers of mRNA vaccine efficacy derived from mechanistic modeling of tumor-immune interactions.

Chrysovalantis Voutouri, Lance L Munn, Triantafyllos Stylianopoulos

Pageof 2

Frequent Collaborators

10 joint publications

Triantafyllos Stylianopoulos

5 joint publications

Myrofora Panagi

5 joint publications

Fotios Mpkeris

4 joint publications

Christina Michael